A carregar...

Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report

Abstract This study presents the first detailed pharmacokinetic data of alectinib and its metabolite M4 in a patient with anaplastic lymphoma kinase (ALK)‐rearranged lung adenocarcinoma undergoing hemodialysis. When the patient was administered a daily 300 mg bid dose of alectinib, the maximal obser...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ji Eun Park, Young‐Ran Yoon, Chang Ho Kim, Jaehee Lee
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2022-04-01
Colecção:Thoracic Cancer
Assuntos:
M4
Acesso em linha:https://doi.org/10.1111/1759-7714.14357
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!